Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Pediatr. 2016 Feb 2;171:128–132. doi: 10.1016/j.jpeds.2016.01.019

Table 1.

Selected Demographics of Study Population

Demographic Entire Study Population (n=553) Agreed to STI Screening (n=326) Declined STI Screening (n=227) p-value*
Mean age, years (SD) 16.1 (1.8) 16.4 (1.8) 15.8 (1.6) <0.001
Gender, n (%) Female 290 (52.4) 162 (49.7) 128 (56.4) 0.12
Male 263 (47.6) 164 (50.3) 99 (43.6)
Racial/Ethnic Group, n (%) Non-Hispanic White 40 (7.3) 21 (6.5) 19 (8.5) 0.66
Non-Hispanic Black 376 (68.9) 220 (68.3) 156 (69.6)
Hispanic 81 (14.8) 49 (15.2) 32 (14.3)
Other 49 (9.0) 32 (9.9) 17 (7.6)
Insurance Status Private 158 (28.6) 77 (23.6) 81 (35.7) 0.001
Governmental 375 (67.8) 241 (73.9) 134 (59.0)
Uninsured 20 (3.6) 8 (2.5) 12 (5.3)
Primary Care Provider Identification 480 (88.2) 280 (87.2) 200 (89.7) 0.38
Preferential Use of ED When Sick 128 (23.2) 83 (25.5) 45 (19.8) 0.12
Sexual Experience Denied Sexual Activity 289 (52.3%) 142 (43.6%) 147 (64.8%) <0.001
Sexually Active, Denied High Risk Activity 164 (29.7%) 107 (32.8%) 57 (25.1%)
High Risk Sexual Activity 100 (18.1%) 77 (23.6%) 23 (10.1%)

P-values are reported as comparison between participants who agreed to STI screening and those who declined using chi2 testing.